Titles
- COVID-19: Federal efforts to provide vaccines to racial and ethnic groups : report to congressional committees1
- COVID-19: HHS and DOD transitioned vaccine responsibilities to HHS, but need to address outstanding issues : report to congressional addressees1
- COVID-19: Information on HHS's public education campaign : report to congressional committees1
- COVID-19: Pandemic lessons highlight need for public health situational awareness network : report to congressional addressees1
- Cancer clinical trial eligibility criteria: available therapy in non-curative settings1
- Center for Devices and Radiological Health (CDRH) appeals processes: Guidance for industry and Food and Drug Administration staff1
- Certain Medicare beneficiaries, such as urban and Hispanic beneficiaries, were more likely than others to use telehealth during the first year of the COVID-19 pandemic1
- Certain ophthalmic products: policy regarding compliance with 21 CFR part 41
- Changes in ownership of skilled nursing facilities from 2016 to 2021: variation by geographic location and quality1
- Charting the path forward for child care: using cost modeling to design new solutions1
- Chronic hepatitis B virus infection: developing drugs for treatment1
- Clinical decision support software: guidance for industry and Food and Drug Administration staff1
- Coast Guard health care: improvements needed for determining staffing needs and monitoring access to care : report to congressional committees1
- Combating the opioid crisis: ‘smarter spending’ to enhance the federal response1
- Comparability Protocols for postapproval changes to the chemistry, manufacturing, and controls information in an NDA, ANDA, or BLA: guidance for industry1
- Competitive generic therapies: guidance for industry1
- Compounding certain beta-lactam products in shortage under Section 503A of the Federal Food, Drug, and Cosmetic Act: immediately in effect guidance for industry1
- Computer-assisted detection devices applied to radiology images and radiology device data: premarket notification [510(k)] submissions : guidance for industry and Food and Drug Administration staff1
- Connecticut Medicaid Fraud Control Unit: 2021 inspection1
- Contact tracing for air travel: CDC’s data system needs substantial improvement : report to congressional addressees1